Long-Term Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

被引：0

作者：

Rubin, David T. ^{[1
]}

Cree, Bruce A. C. ^{[2
]}

Wolf, Douglas C. ^{[3
]}

Alekseeva, Olga ^{[4
]}

Charles, Lorna ^{[5
]}

Petersen, AnnKatrin ^{[5
]}

Sheffield, James K. ^{[5
]}

Cheng, Chun-Yen ^{[5
]}

Riolo, Jon V. ^{[5
]}

Silva, Diego ^{[5
]}

Lublin, Fred D. ^{[6
]}

Cohen, Jeffrey A. ^{[7
]}

Danese, Silvio ^{[8
]}

机构：

[1] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA

[2] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA USA

[3] Atlanta Gastroenterol Associates, Ctr Crohns Dis & Ulcerat Colitis, Atlanta, GA USA

[4] Nizhny Novgorod Reg Clin Hosp, Nizhnii Novgorod, Nizhegorod, Russia

[5] Bristol Myers Squibb, Princeton, NJ USA

[6] Mt Sinai Med Ctr, New York, NY USA

[7] Cleveland Clin, Mellen Ctr MS Treatment & Res, Cleveland, OH USA

[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst, Milan, Lombardia, Italy

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S911

引用

下载

页码：S680 / S680

页数：1

共 50 条

[1] Long-term Safety of Ozanimod in Relapsing Multiple Sclerosis and Moderately to Severely Active Ulcerative Colitis
Cree, Bruce A. C.
Danese, Silvio
Wolf, Douglas C.
Alekseeva, Olga
Charles, Lorna
Petersen, AnnKatrin
Sheffield, James K.
Cheng, Chun-Yen
Riolo, Jon V.
Silva, Diego
Lublin, Fred D.
Rubin, David T.
Cohen, Jeffrey A.
NEUROLOGY, 2023, 100 (17)
[2] Long-term Safety of Ozanimod in Patients with Moderately to Severely Active Ulcerative Colitis (UC) and Relapsing Multiple Sclerosis (RMS) Studies
Rubin, David T.
Wolf, Douglas C.
Alekseeva, Olga
Charles, Lorna
Afsari, Sonia
Petersen, Ann Katrin
Sheffield, James
Li, Hongjuan
Silva, Diego
Lublin, Fred D.
Cree, Bruce
Cohen, Jeffrey
Danese, Silvio
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S396 - S396
[3] Long-term use of ozanimod in patients with moderately to severely active Ulcerative Colitis
Danese, S.
Colombel, J. F.
Ponich, T.
Jovanovic, I.
Bossuyt, P.
Longman, R.
Alekseeva, O.
Petersen, A.
Chitkara, D.
Marta, C.
Charles, L.
Rubin, D. T.
Afzali, A.
Loftus, E. V.
Wolf, D. C.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I093 - I094
[4] LONG-TERM USE OF OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Wolf, Douglas C.
Colombel, Jean Frederic
Ponich, Terry P.
Jovanovic, Igor
Bossuyt, Peter
Longman, Randy
Alekseeva, Olga
Petersen, AnnKatrin
Chitkara, Denesh
Marta, Cecilia
Charles, Lorna
Rubin, David T.
Afzali, Anita
Loftus, Edward V.
Danese, Silvio
GASTROENTEROLOGY, 2022, 162 (07) : S969 - S969
[5] Long-term use of ozanimod in patients with moderately to severely active ulcerative colitis
Danese, S.
Colombel, J-F
Ponich, T.
Jovanovic, I.
Bossuyt, P.
Longman, R.
Alekseeva, O.
Petersen, A. K.
Marta, C.
Charles, L.
Sparrow, M.
Rubin, D. T.
Afzali, A.
Loftus, E. V., Jr.
Wolf, D. C.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 125 - 126
[6] Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis
Millie, Long
Raymond, Cross
Jonathan, Calkwood
Marc, Pondel
Ashwini, Pai
Harris, Ahmad
Lorna, Charles
Ayanbola, Elegbe
AnnKatrin, Petersen
James, Sheffield
Adil, Javed
Douglas, Wolf
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S9 - S10
[7] Long-term cardiac safety of ozanimod in phase 3 clinical program of Ulcerative Colitis and relapsing multiple sclerosis
Armuzzi, A.
Cross, R. K.
Lichtenstein, G.
Calkwood, J.
Pai, A.
Pondel, M.
Ahmad, H. A.
Charles, L.
Elegbe, A.
Petersen, A.
Sheffield, J. K.
Javed, A.
Hou, J.
Regueiro, M.
Wolf, D. C.
Long, M.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I094 - I095
[8] Long-term cardiac safety of ozanimod in Phase 3 clinical program of ulcerative colitis and relapsing multiple sclerosis
Armuzzi, A.
Cross, R. K.
Lichtenstein, G. R.
Calkwood, J.
Ahmad, H. A.
Charles, L.
Elegbe, A.
Petersen, A. K.
Sheffield, J. K.
Sparrow, M.
Javed, A.
Hou, J.
Regueiro, M.
Wolf, D. C.
Long, M.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 126 - 127
[9] LONG-TERM CARDIAC SAFETY OF OZANIMOD IN PHASE 3 CLINICAL PROGRAM OF ULCERATIVE COLITIS AND RELAPSING MULTIPLE SCLEROSIS
Long, Millie D.
Cross, Raymond K.
Lichtenstein, Gary R.
Calkwood, Jonathan
Pai, Ashwini
Pondel, Marc
Ahmad, Harris
Charles, Lorna
Elegbe, Ayanbola
Petersen, AnnKatrin
Sheffield, James K.
Javed, Adil
Hou, Jason K.
Regueiro, Miguel D.
Wolf, Douglas C.
Armuzzi, Alessandro
GASTROENTEROLOGY, 2022, 162 (07) : S5 - S6
[10] COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND USTEKINUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Dubinsky, Marla C.
Betts, Keith
Eren, Devrim
Tang, Wenxi
Yin, Lei
Gupte-Singh, Komal
GASTROENTEROLOGY, 2022, 162 (07) : S603 - S603

← 1 2 3 4 5 →